| 发明名称 | Phosphoinositide 3-kinase inhibitor with a zinc binding moiety | ||
| 摘要 | The invention provides a compound of Formula I,; Pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase. | ||
| 申请公布号 | US9249156(B2) | 申请公布日期 | 2016.02.02 |
| 申请号 | US201414197769 | 申请日期 | 2014.03.05 |
| 申请人 | Curis, Inc. | 发明人 | Cai Xiong;Zhai Haixiao;Lai Chengjung;Qian Changgeng;Bao Rudi |
| 分类号 | C07D495/14;C07D239/70;C07D413/14;A61K31/535;C07D495/04 | 主分类号 | C07D495/14 |
| 代理机构 | Elmore Patent Law Group, P.C. | 代理人 | Elmore Patent Law Group, P.C. ;Harlan Edgar W.;Elmore Carolyn S. |
| 主权项 | 1. A salt of a compound represented by the formula:wherein said salt is a benzenesulfonate salt or a methanesulfonate salt. | ||
| 地址 | Lexington MA US | ||